Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Research reveals new insights into the role of efferocytosis in pancreatic cancer liver metastasis

Research reveals new insights into the role of efferocytosis in pancreatic cancer liver metastasis

Study pinpoints a protein linked to metastatic pancreatic cancer

Study pinpoints a protein linked to metastatic pancreatic cancer

Study links specific inflammatory markers to increased cancer risk

Study links specific inflammatory markers to increased cancer risk

New vaccine may be potential off-the-shelf treatment for pancreatic, colorectal cancer

New vaccine may be potential off-the-shelf treatment for pancreatic, colorectal cancer

Engrailed-1 protein promotes pancreatic cancer progression and metastasis

Engrailed-1 protein promotes pancreatic cancer progression and metastasis

OU research focuses on innovative combination of imaging techniques to detect pancreatic cancer

OU research focuses on innovative combination of imaging techniques to detect pancreatic cancer

Overweight and obesity linked to rising death rates from bowel cancer among young adults

Overweight and obesity linked to rising death rates from bowel cancer among young adults

Study addresses knowledge gap of clinical features and outcomes of Black patients with melanoma

Study addresses knowledge gap of clinical features and outcomes of Black patients with melanoma

Unintentional weight loss linked to increased risk of cancer diagnosis

Unintentional weight loss linked to increased risk of cancer diagnosis

Annexin-A1 targeted therapy beats several cancers

Annexin-A1 targeted therapy beats several cancers

Drinkable, carbon monoxide-infused foam supercharges cancer therapy

Drinkable, carbon monoxide-infused foam supercharges cancer therapy

Risk of gastrointestinal cancers translates to one in 12 people developing, and one in 16 people dying from, gastrointestinal cancers

Risk of gastrointestinal cancers translates to one in 12 people developing, and one in 16 people dying from, gastrointestinal cancers

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors

Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors

New drug screening system helps uncover promising target for pancreatic cancer treatments

New drug screening system helps uncover promising target for pancreatic cancer treatments

Protein "on/off switch" controls breast cancer spread and immunotherapy response

Protein "on/off switch" controls breast cancer spread and immunotherapy response

Metabolic syndrome linked to higher pancreatic cancer risk, study shows

Metabolic syndrome linked to higher pancreatic cancer risk, study shows

Trends in mortality from leading cancers from 2002 to 2019 for the 314 districts in England

Trends in mortality from leading cancers from 2002 to 2019 for the 314 districts in England

Study: Risk of dying from cancer depends on where you live in England

Study: Risk of dying from cancer depends on where you live in England

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.